Showing results (2511-2520 of 2,814) with videos related to

Sort By:
Pageof 282
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2016
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective AnalysisJustin F Gainor, Alice T Shaw, Lecia V Sequist, et al.
The New England Journal of Medicine|June 21, 2018
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing LossPenelope R Brock, Rudolf Maibach, Margaret Childs, et al.
Reviews in Medical Virology|July 31, 2026
Convalescent Plasma Restores Viral Clearance After Anti-Spike Monoclonal Antibody Failure in Immunocompromised COVID-19 Patients: A Systematic Review and Meta-Analysis of Individual Patient DataDaniele Focosi, Tommaso Francesco Aiello, Arturo Casadevall, et al.
European Journal of Cancer (Oxford, England : 1990)|October 12, 2023
Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanomaRachel S Goodman, Lorenza Di Guardo, Andrea Maurichi, et al.
Cancer|August 6, 2013
Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experienceJason J Luke, Margaret K Callahan, Michael A Postow, et al.
Cancer|August 18, 2016
The efficacy of anti-PD-1 agents in acral and mucosal melanomaAlexander N Shoushtari, Rodrigo R Munhoz, Deborah Kuk, et al.
Cell|May 6, 1998
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationD L Lacey, E Timms, H L Tan, et al.
Journal of the American College of Cardiology|March 24, 2018
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed S Mahmood, Michael G Fradley, Justine V Cohen, et al.
Nature Communications|April 7, 2022
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogrammingZhaowei Chu, Lei Gu, Yeguang Hu, et al.
Nature Communications|January 30, 2016
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapyDouglas B Johnson, Monica V Estrada, Roberto Salgado, et al.
Pageof 282